Martin Malmberg

2.5k total citations
46 papers, 997 citations indexed

About

Martin Malmberg is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Martin Malmberg has authored 46 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Martin Malmberg's work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Genomics and Diagnostics (10 papers). Martin Malmberg is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Genomics and Diagnostics (10 papers). Martin Malmberg collaborates with scholars based in Sweden, United States and Germany. Martin Malmberg's co-authors include Åke Borg, Johan Vallon‐Christersson, Lao H. Saal, Lisa Rydén, Cecilia Hegardt, Niklas Loman, Anna Ehinger, Jari Häkkinen, Jonas Manjer and Dorthe Grabau and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Martin Malmberg

45 papers receiving 979 citations

Peers

Martin Malmberg

ONCOL

PRM

GENET

Sonali Jindal United States

Jacqueline A. Hall United Kingdom

Niklas Loman Sweden

Jin-Song Lu China

María Peña-Chilet Spain

Silvia J. Serrano‐Gómez Colombia

Syed A. Ahmed United States

Anne O’Dea United States

David Dearnaley United Kingdom

Chiu-Kit Tse United States

Sonali Jindal United States

Martin Malmberg

882 ×1.9

ONCOL

323 ×0.7

327 ×0.8

144 ×0.8

PRM

127 ×0.8

GENET

Citations per year, relative to Martin Malmberg Martin Malmberg (= 1×) peers Sonali Jindal

Countries citing papers authored by Martin Malmberg

Since Specialization

Citations

This map shows the geographic impact of Martin Malmberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Malmberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Malmberg more than expected).

Fields of papers citing papers by Martin Malmberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Malmberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Malmberg. The network helps show where Martin Malmberg may publish in the future.

Co-authorship network of co-authors of Martin Malmberg

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Malmberg. A scholar is included among the top collaborators of Martin Malmberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Malmberg. Martin Malmberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kimbung, Siker, Srinivas Veerla, Anna Ehinger, et al.. (2025). Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort. Clinical Cancer Research. 31(13). 2695–2709. 1 indexed citations

Saal, Lao H., Niklas Loman, Yilun Chen, et al.. (2024). Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.. Journal of Clinical Oncology. 42(16_suppl). 568–568. 1 indexed citations

Demircan, Kamil, Thilo Samson Chillon, Johan Vallon‐Christersson, et al.. (2023). Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study. Journal of Translational Medicine. 21(1). 1 indexed citations

Demircan, Kamil, Johan Vallon‐Christersson, Martin Malmberg, et al.. (2023). Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study. Redox Biology. 63. 102728–102728. 18 indexed citations

Demircan, Kamil, Qian Sun, Petra Seemann, et al.. (2022). Autoimmunity to selenoprotein P predicts breast cancer recurrence. Redox Biology. 53. 102346–102346. 13 indexed citations

Vallon‐Christersson, Johan, Johan Staaf, Jari Häkkinen, et al.. (2022). 52P RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. Annals of Oncology. 33. S144–S145.

Dahlgren, Malin, Anthony M. George, Christian Brueffer, et al.. (2021). Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer. JNCI Cancer Spectrum. 5(2). 16 indexed citations

Brueffer, Christian, Christof Winter, Johan Vallon‐Christersson, et al.. (2020). The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome. EMBO Molecular Medicine. 12(10). e12118–e12118. 42 indexed citations

Vallon‐Christersson, Johan, Jari Häkkinen, Cecilia Hegardt, et al.. (2019). Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series. Scientific Reports. 9(1). 12184–12184. 36 indexed citations

10.

Vallon‐Christersson, Johan, Cecilia Hegardt, Lao H. Saal, et al.. (2019). Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. Clinical Cancer Research. 25(21). 6368–6381. 37 indexed citations

11.

Foukakis, Theodoros, John Lövrot, Alexios Matikas, et al.. (2018). Immune gene expression and response to chemotherapy in advanced breast cancer. British Journal of Cancer. 118(4). 480–488. 37 indexed citations

12.

Brueffer, Christian, Johan Vallon‐Christersson, Dorthe Grabau, et al.. (2018). Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative. JCO Precision Oncology. 2(2). 1–18. 124 indexed citations

13.

Tobin, Nicholas P., Arian Lundberg, Linda S. Lindström, et al.. (2017). PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients. Clinical Cancer Research. 23(23). 7225–7231. 10 indexed citations

14.

Weller, David, Peter Vedsted, Chantelle Anandan, et al.. (2016). An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation. BMJ Open. 6(7). e009641–e009641. 36 indexed citations

15.

Winter, Christof, Martin Nilsson, Eric Olsson, et al.. (2016). Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Annals of Oncology. 27(8). 1532–1538. 105 indexed citations

16.

Saal, Lao H., Johan Vallon‐Christersson, Jari Häkkinen, et al.. (2015). The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Medicine. 7(1). 20–20. 141 indexed citations

17.

Suzuki, Takayuki, Lennart Blomqvist, Thomas Hatschek, et al.. (2013). Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy. Medical Oncology. 30(1). 415–415. 6 indexed citations

18.

Bjöhle, Judith, Jenny Bergqvist, J. Simon Gronowitz, et al.. (2013). Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial. Breast Cancer Research and Treatment. 139(3). 751–758. 28 indexed citations

19.

Hatschek, Thomas, Lena Carlsson, Zakaria Einbeigi, et al.. (2011). Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial. Breast Cancer Research and Treatment. 131(3). 939–947. 23 indexed citations

20.

Malmberg, Martin, Harry K. Slocum, & Youcef M. Rustum. (1991). A Model for Mimicking the Pharmacokinetics of Chemotherapy Drugs for Evaluation of Drug Effects in a Soft Agar Colony Formation Assay System. PubMed. 7(4). 159–164. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact